EMA Authorised: Entacapone Teva (entacapone) — Teva Pharma B.V.

View source ↗

Summary

Entacapone Teva has been authorised for use in the treatment of Parkinson's disease in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Entacapone Teva (entacapone)

Snippet

Status: Authorised. Therapeutic area: Parkinson Disease. MAH: Teva Pharma B.V.. Decision date: 10/09/2021